Premium
Teriflunomide for relapsing remitting multiple sclerosis
Author(s) -
Chaplin Steve,
Schmierer Klaus
Publication year - 2015
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1384
Subject(s) - teriflunomide , medicine , multiple sclerosis , relapsing remitting , physical therapy , physical medicine and rehabilitation , immunology , fingolimod
Teriflunomide (Aubagio) is licensed for the treatment of adults with RRMS. Here, Steve Chaplin presents the clinical data relating to its efficacy and Dr Schmierer discusses its place in therapy.